Haemonetics (HAE) Tops Q2 EPS by 15c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.73 +0.30%
EPS Growth %: +1.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: +1.6%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q2 EPS of $0.83, $0.15 better than the analyst estimate of $0.68. Revenue for the quarter came in at $297.48 million versus the consensus estimate of $270.46 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- DA Davidson Reiterates Buy Rating on Vulcan Materials Company (VMC)
- Rubico to shift from semi-annual to quarterly financial reporting
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
